BDNF and Alzheimer disease: In addition, the study detected a correlation between the proBNF/BDNF ratio and the loss of dendritic spines across ages, which is related to Alzheimer’s development, suggesting that the proBDNF/BDNF ratio may serve as a biomarker and therapeutic target for AD treatment.